Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Aug;85(4):493–495. doi: 10.1054/bjoc.2001.1979

Neuroblastoma in monozygotic twins – a case of probable twin-to-twin metastasis

J Anderson 1,#, H Kempski 1,#, L Hill 3, D Rampling 2, T Gordon 4, A Michalski 1
PMCID: PMC2364085  PMID: 11506485

Abstract

Concordance for neuroblastoma in monozygotic twins has been reported only rarely, and the cause of the shared pathology has not been established. We describe a case of infant monozygotic twins developing tumours that were morphologically, clinically and molecularly indistinguishable, but with a delay of 6 months between times of presentation. Both tumours were metastatic and had amplification of MYCN and deletion at 1p36. Twin 1, who developed neuroblastoma first, had constitutional karyotype abnormalities in at least 5% of peripheral blood mononuclear cells involving 1p and 3p, and a deletion of 1q44 in 21% of cells. Twin 2 had a normal constitutional karyotype and lacked rearrangement or deletion of these regions. We propose an acquired neuroblastoma predisposition specific for twin 1, and in utero metastatic spread of tumour cells to twin 2 via the shared placental circulation. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: neuroblastoma, monozygotic twins

Full Text

The Full Text of this article is available as a PDF (36.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biegel J. A., White P. S., Marshall H. N., Fujimori M., Zackai E. H., Scher C. D., Brodeur G. M., Emanuel B. S. Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet. 1993 Jan;52(1):176–182. [PMC free article] [PubMed] [Google Scholar]
  2. Boyd T. K., Schofield D. E. Monozygotic twins concordant for congenital neuroblastoma: case report and review of the literature. Pediatr Pathol Lab Med. 1995 Nov-Dec;15(6):931–940. doi: 10.3109/15513819509027029. [DOI] [PubMed] [Google Scholar]
  3. Breen C. J., O'Meara A., McDermott M., Mullarkey M., Stallings R. L. Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet. 2000 Jul 1;120(1):44–49. doi: 10.1016/s0165-4608(99)00252-6. [DOI] [PubMed] [Google Scholar]
  4. Brodeur G. M., Green A. A., Hayes F. A., Williams K. J., Williams D. L., Tsiatis A. A. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res. 1981 Nov;41(11 Pt 1):4678–4686. [PubMed] [Google Scholar]
  5. Buckley J. D., Buckley C. M., Breslow N. E., Draper G. J., Roberson P. K., Mack T. M. Concordance for childhood cancer in twins. Med Pediatr Oncol. 1996 Apr;26(4):223–229. doi: 10.1002/(SICI)1096-911X(199604)26:4<223::AID-MPO1>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  6. Ejeskär K., Aburatani H., Abrahamsson J., Kogner P., Martinsson T. Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene. Br J Cancer. 1998 Jun;77(11):1787–1791. doi: 10.1038/bjc.1998.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gilbert F., Balaban G., Moorhead P., Bianchi D., Schlesinger H. Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet Cytogenet. 1982 Sep;7(1):33–42. doi: 10.1016/0165-4608(82)90105-4. [DOI] [PubMed] [Google Scholar]
  8. Hallstensson K., Thulin S., Aburatani H., Hippo Y., Martinsson T. Representational difference analysis and loss of heterozygosity studies detect 3p deletions in neuroblastoma. Eur J Cancer. 1997 Oct;33(12):1966–1970. doi: 10.1016/s0959-8049(97)00228-1. [DOI] [PubMed] [Google Scholar]
  9. Kushner B. H., Helson L. Monozygotic siblings discordant for neuroblastoma: etiologic implications. J Pediatr. 1985 Sep;107(3):405–409. doi: 10.1016/s0022-3476(85)80515-1. [DOI] [PubMed] [Google Scholar]
  10. Laureys G., Speleman F., Opdenakker G., Benoit Y., Leroy J. Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma. Genes Chromosomes Cancer. 1990 Sep;2(3):252–254. doi: 10.1002/gcc.2870020315. [DOI] [PubMed] [Google Scholar]
  11. Laureys G., Speleman F., Versteeg R., van der Drift P., Chan A., Leroy J., Francke U., Opdenakker G., Van Roy N. Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers. Oncogene. 1995 Mar 16;10(6):1087–1093. [PubMed] [Google Scholar]
  12. Laureys G., Versteeg R., Speleman F., van der Drift P., Francke U., Opdenakker G., Van Roy N. Characterisation of the chromosome breakpoints in a patient with a constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12) and neuroblastoma. Eur J Cancer. 1995;31A(4):523–526. doi: 10.1016/0959-8049(95)00012-8. [DOI] [PubMed] [Google Scholar]
  13. Mancini A. F., Rosito P., Faldella G., Serra L., Vallicelli R., Vecchi V., Vivarelli F., Paolucci G. Neuroblastoma in a pair of identical twins. Med Pediatr Oncol. 1982;10(1):45–51. doi: 10.1002/mpo.2950100108. [DOI] [PubMed] [Google Scholar]
  14. Mead R. S., Cowell J. K. Molecular characterization of a (1;10)(p22;q21) constitutional translocation from a patient with neuroblastoma. Cancer Genet Cytogenet. 1995 Jun;81(2):151–157. doi: 10.1016/0165-4608(94)00216-x. [DOI] [PubMed] [Google Scholar]
  15. Mertens F., Johansson B., Höglund M., Mitelman F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res. 1997 Jul 1;57(13):2765–2780. [PubMed] [Google Scholar]
  16. Mitchell E. L., McNally K., Kelsey A. Involvement of chromosomes 1 and 17 in a case of neuroblastoma. Pediatr Hematol Oncol. 1996 Sep-Oct;13(5):457–461. doi: 10.3109/08880019609030858. [DOI] [PubMed] [Google Scholar]
  17. Rudolph B., Harbott J., Lampert F. Fragile sites and neuroblastoma: fragile site at 1p13.1 and other points on lymphocyte chromosomes from patients and family members. Cancer Genet Cytogenet. 1988 Mar;31(1):83–94. doi: 10.1016/0165-4608(88)90015-5. [DOI] [PubMed] [Google Scholar]
  18. Schleiermacher G., Peter M., Michon J., Hugot J. P., Vielh P., Zucker J. M., Magdelénat H., Thomas G., Delattre O. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer. 1994 Aug;10(4):275–281. doi: 10.1002/gcc.2870100409. [DOI] [PubMed] [Google Scholar]
  19. Van Roy N., Laureys G., Van Gele M., Opdenakker G., Miura R., van der Drift P., Chan A., Versteeg R., Speleman F. Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes. Eur J Cancer. 1997 Oct;33(12):1974–1978. doi: 10.1016/s0959-8049(97)00319-5. [DOI] [PubMed] [Google Scholar]
  20. Vernole P., Tedeschi B., Caporossi D., Nicoletti B. Fragile site 1p13.1 in neuroblastoma patients. Cancer Genet Cytogenet. 1989 Jul 1;40(1):135–136. doi: 10.1016/0165-4608(89)90155-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES